vs

Side-by-side financial comparison of MEDIFAST INC (MED) and Shimmick Corp (SHIM). Click either name above to swap in a different company.

Shimmick Corp is the larger business by last-quarter revenue ($141.9M vs $75.1M, roughly 1.9× MEDIFAST INC). MEDIFAST INC produced more free cash flow last quarter ($-6.6M vs $-28.7M). Over the past eight quarters, Shimmick Corp's revenue compounded faster (-10.1% CAGR vs -34.4%).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

Shimmick Corp is a U.S.-based heavy civil construction firm specializing in building and upgrading critical public infrastructure, including water facilities, transportation systems, dams, and environmental remediation projects. It primarily serves federal, state, and local government clients across North America, delivering complex large-scale construction solutions for public sector segments.

MED vs SHIM — Head-to-Head

Bigger by revenue
SHIM
SHIM
1.9× larger
SHIM
$141.9M
$75.1M
MED
More free cash flow
MED
MED
$22.1M more FCF
MED
$-6.6M
$-28.7M
SHIM
Faster 2-yr revenue CAGR
SHIM
SHIM
Annualised
SHIM
-10.1%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
MED
MED
SHIM
SHIM
Revenue
$75.1M
$141.9M
Net Profit
$-4.4M
Gross Margin
69.4%
7.6%
Operating Margin
-10.4%
-2.2%
Net Margin
-3.1%
Revenue YoY
-36.9%
Net Profit YoY
EPS (diluted)
$-1.64
$-0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MED
MED
SHIM
SHIM
Q4 25
$75.1M
$141.9M
Q3 25
$89.4M
$128.4M
Q2 25
$105.6M
$122.1M
Q1 25
$115.7M
$103.6M
Q4 24
$119.0M
Q3 24
$140.2M
$166.0M
Q2 24
$168.6M
$90.6M
Q1 24
$174.7M
$120.0M
Net Profit
MED
MED
SHIM
SHIM
Q4 25
$-4.4M
Q3 25
$-2.3M
$-8.5M
Q2 25
$2.5M
$-9.8M
Q1 25
$-772.0K
$-38.5M
Q4 24
Q3 24
$1.1M
$-1.6M
Q2 24
$-8.2M
$-51.4M
Q1 24
$8.3M
$-33.3M
Gross Margin
MED
MED
SHIM
SHIM
Q4 25
69.4%
7.6%
Q3 25
69.5%
6.3%
Q2 25
72.6%
3.8%
Q1 25
72.8%
-20.1%
Q4 24
74.1%
Q3 24
75.4%
7.3%
Q2 24
73.2%
-34.4%
Q1 24
72.8%
-13.2%
Operating Margin
MED
MED
SHIM
SHIM
Q4 25
-10.4%
-2.2%
Q3 25
-4.6%
-5.5%
Q2 25
-1.0%
-7.3%
Q1 25
-1.1%
-39.3%
Q4 24
0.6%
Q3 24
1.5%
0.7%
Q2 24
-4.7%
-53.0%
Q1 24
4.5%
-26.5%
Net Margin
MED
MED
SHIM
SHIM
Q4 25
-3.1%
Q3 25
-2.5%
-6.6%
Q2 25
2.3%
-8.0%
Q1 25
-0.7%
-37.1%
Q4 24
Q3 24
0.8%
-0.9%
Q2 24
-4.8%
-56.7%
Q1 24
4.8%
-27.8%
EPS (diluted)
MED
MED
SHIM
SHIM
Q4 25
$-1.64
$-0.12
Q3 25
$-0.21
$-0.25
Q2 25
$0.22
$-0.28
Q1 25
$-0.07
$-0.92
Q4 24
$0.08
Q3 24
$0.10
$-0.05
Q2 24
$-0.75
$-1.83
Q1 24
$0.76
$-1.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MED
MED
SHIM
SHIM
Cash + ST InvestmentsLiquidity on hand
$167.3M
$17.6M
Total DebtLower is stronger
$57.5M
Stockholders' EquityBook value
$198.9M
$-52.7M
Total Assets
$248.0M
$218.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MED
MED
SHIM
SHIM
Q4 25
$167.3M
$17.6M
Q3 25
$173.5M
$21.4M
Q2 25
$162.7M
$16.3M
Q1 25
$164.6M
$33.7M
Q4 24
$162.3M
Q3 24
$170.0M
$26.0M
Q2 24
$163.5M
$22.4M
Q1 24
$156.4M
$27.3M
Total Debt
MED
MED
SHIM
SHIM
Q4 25
$57.5M
Q3 25
$36.4M
Q2 25
$31.4M
Q1 25
$9.5M
Q4 24
Q3 24
$39.9M
Q2 24
Q1 24
$31.5M
Stockholders' Equity
MED
MED
SHIM
SHIM
Q4 25
$198.9M
$-52.7M
Q3 25
$214.7M
$-49.5M
Q2 25
$216.0M
$-42.6M
Q1 25
$211.0M
$-34.7M
Q4 24
$210.1M
Q3 24
$207.3M
$973.0K
Q2 24
$205.3M
$436.0K
Q1 24
$211.0M
$38.1M
Total Assets
MED
MED
SHIM
SHIM
Q4 25
$248.0M
$218.5M
Q3 25
$268.2M
$203.0M
Q2 25
$269.3M
$227.7M
Q1 25
$280.0M
$233.9M
Q4 24
$284.2M
Q3 24
$291.2M
$346.7M
Q2 24
$293.5M
$344.5M
Q1 24
$302.8M
$378.0M
Debt / Equity
MED
MED
SHIM
SHIM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
41.01×
Q2 24
Q1 24
0.83×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MED
MED
SHIM
SHIM
Operating Cash FlowLast quarter
$-5.3M
$-23.7M
Free Cash FlowOCF − Capex
$-6.6M
$-28.7M
FCF MarginFCF / Revenue
-8.8%
-20.2%
Capex IntensityCapex / Revenue
1.8%
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.2M
$-27.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MED
MED
SHIM
SHIM
Q4 25
$-5.3M
$-23.7M
Q3 25
$12.1M
$-3.8M
Q2 25
$-3.4M
$-38.2M
Q1 25
$3.4M
$44.9M
Q4 24
$-4.9M
Q3 24
$9.1M
$12.7M
Q2 24
$13.1M
$-43.9M
Q1 24
$7.3M
$-35.0M
Free Cash Flow
MED
MED
SHIM
SHIM
Q4 25
$-6.6M
$-28.7M
Q3 25
$10.8M
$-4.2M
Q2 25
$-4.8M
$-38.7M
Q1 25
$1.9M
$44.4M
Q4 24
$-7.2M
Q3 24
$7.7M
$10.3M
Q2 24
$11.1M
$-46.8M
Q1 24
$5.4M
$-39.6M
FCF Margin
MED
MED
SHIM
SHIM
Q4 25
-8.8%
-20.2%
Q3 25
12.0%
-3.2%
Q2 25
-4.5%
-31.7%
Q1 25
1.6%
42.9%
Q4 24
-6.1%
Q3 24
5.5%
6.2%
Q2 24
6.6%
-51.7%
Q1 24
3.1%
-33.0%
Capex Intensity
MED
MED
SHIM
SHIM
Q4 25
1.8%
3.5%
Q3 25
1.5%
0.3%
Q2 25
1.3%
0.4%
Q1 25
1.3%
0.5%
Q4 24
1.9%
Q3 24
1.0%
1.4%
Q2 24
1.1%
3.3%
Q1 24
1.1%
3.8%
Cash Conversion
MED
MED
SHIM
SHIM
Q4 25
Q3 25
Q2 25
-1.36×
Q1 25
Q4 24
Q3 24
8.04×
Q2 24
Q1 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MED
MED

Segment breakdown not available.

SHIM
SHIM

Shimmick Projects$106.8M75%
Non Core Projects$35.1M25%

Related Comparisons